Filing Details
- Accession Number:
- 0000899243-21-008447
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-02-26 17:47:31
- Reporting Period:
- 2021-02-24
- Accepted Time:
- 2021-02-26 17:47:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1797336 | Ayala Pharmaceuticals Inc. | AYLA | Biological Products, (No Disgnostic Substances) (2836) | 823578375 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1811354 | B. Gary Gordon | Oppenheimer 4 Rehovot L3 7670104 | Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-02-24 | 3,000 | $5.16 | 11,520 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-02-24 | 3,000 | $17.46 | 8,520 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2021-02-24 | 3,000 | $0.00 | 3,000 | $5.16 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 89,000 | 2029-09-19 | No | 4 | M | Direct |
Footnotes
- The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- This option vested and became exercisable as to 25% of the underlying shares of common stock on August 1, 2020 and will become vested and exercisable as to the remainder of the shares in 12 equal quarterly installments thereafter.
Billionaire Hedge Funds
